Mike Outwin

Glympse’s mission is to measure protein activity to transform the way patients are diagnosed, monitored and treated. At Glympse, you’ll find an entrepreneurial team that shares a commitment to excellence, an impatience with the status quo, and a desire to drive innovation for patients in need.

Sunbird Bio is a leader in protein-based diagnostic tests, becoming the first company to overcome the challenge of accurately detecting and differentiating the specific proteins that aggregate, and therefore signal the presence of Alzheimer’s disease, with a simple blood draw. We are addressing the tremendous, growing need for more reliable and sensitive diagnostic tests to accelerate drug development and enhance patient care. Our pipeline of innovative, non-invasive technologies, such as our APEX technology, will empower researchers and clinicians with unparalleled insights not available from current tests.

Jetti makes it possible to extract copper from low-grade primary sulfides, such as chalcopyrite, the world’s most abundant copper mineral ore. Jetti’s commercially proven and proprietary catalytic technology addresses the key technical problem preventing recovery of trillions of dollars of trapped resources. We apply our catalysts to hundreds of millions of tons of ore, and significantly increase copper yields in a cost effective and environmentally responsible manner.

GreatPoint Ventures is an early-stage venture capital firm founded by entrepreneurs and operators whove built companies cumulatively worth $300 billion. We invest between $250k and $20m into Seed, A, and B rounds, most often leading Series As. Our mission is to partner with entrepreneurs solving big problems across enterprise, healthcare, bio-tech, and food. At GPV we make fewer than 10 new investments per year so we have time to fight in the trenches with every team we back.

Glympse’s mission is to measure protein activity to transform the way patients are diagnosed, monitored and treated. At Glympse, you’ll find an entrepreneurial team that shares a commitment to excellence, an impatience with the status quo, and a desire to drive innovation for patients in need.

Sunbird Bio is a leader in protein-based diagnostic tests, becoming the first company to overcome the challenge of accurately detecting and differentiating the specific proteins that aggregate, and therefore signal the presence of Alzheimer’s disease, with a simple blood draw. We are addressing the tremendous, growing need for more reliable and sensitive diagnostic tests to accelerate drug development and enhance patient care. Our pipeline of innovative, non-invasive technologies, such as our APEX technology, will empower researchers and clinicians with unparalleled insights not available from current tests.

Jetti makes it possible to extract copper from low-grade primary sulfides, such as chalcopyrite, the world’s most abundant copper mineral ore. Jetti’s commercially proven and proprietary catalytic technology addresses the key technical problem preventing recovery of trillions of dollars of trapped resources. We apply our catalysts to hundreds of millions of tons of ore, and significantly increase copper yields in a cost effective and environmentally responsible manner.